跳至主要内容
临床试验/NCT05899023
NCT05899023招募中不适用

Identifying Risk Factors for Poor Glycemic Control Among Emergency Department Patients and Improving Linkage to Outpatient Care

NYU Langone Health1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2025年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
1
主要终点
Percent of Patients who Complete at least One In-Person Follow-up Outpatient Visit

研究概览

简要总结

This goal of this NIH funded R01 study is to identify risk factors for not being able to follow-up for a new diagnosis of diabetes in the emergency department and improve linkage of these newly diagnosed patients to appropriate outpatient care. Its three aims will be accomplished through 1) a retrospective chart review of emergency department (ED) patients screened for diabetes, 2) a series of prospective qualitative interviews among ED patients with newly diagnosed diabetes who fail to follow-up for outpatient care, and 3) a simple randomized controlled trial to test the efficacy of telehealth bridge visits to connect ED patients with newly diagnosed diabetes to outpatient primary care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Emergency patient receiving lab tests with an initial HbA1c test result of ≥ 6.5%
  • •Residential address in New York City or Long Island
  • •Primary language is English or Spanish
  • •Able to provide informed consent

排除标准

  • •No prior history of diabetes
  • •No medical condition that would result in a spurious HbA1c test (e.g., sickle cell, recent blood loss)

研究组 & 干预措施

Telehealth Bridge Visits

Experimental

Patients in the experimental arm will receive post-emergency department telehealth bridge visits to connect ED patients with newly diagnosed diabetes to outpatient primary care.

干预措施: Telehealth Bridge Visits (Other)

Control

Active Comparator

Patients in the control arm will receive standard of care.

干预措施: Standard of Care (Other)

结局指标

主要结局

Percent of Patients who Complete at least One In-Person Follow-up Outpatient Visit

时间窗: Up to Month 6 Post-Diagnosis

A follow-up outpatient visit excludes the telehealth visits assigned to the experimental group. This outcome will be tracked using phone calls and data from Healthix, a regional health information exchange.

次要结局

  • Percent of Patients who Complete at least One Follow-Up Hemoglobin A1C (HbA1c) Test within 6 Months of Diagnosis(Up to Month 6 Post-Diagnosis)
  • Percent of Patients who Complete at least One Follow-Up Hemoglobin A1C (HbA1c) Test within 12 Months of Diagnosis(Up to Month 12 Post-Diagnosis)
  • Percent of Patients who Start on Diabetes Medications within 6 Months of Diagnosis(Up to Month 6 Post-Diagnosis)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验